HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705.

Abstract
High-affinity ligands of non-peptidic nature, binding to the class I major histocompatibility complex protein HLA B*2705 whose expression is strongly linked to the pathogenesis of the autoimmune disease ankylosing spondylitis, should give way to a selective immunotherapy by blocking or antagonising the interaction with autoreactive T cell clones. Here we present experimental data on the binding of modified peptides, designed to optimally bind to HLA-B*2705 by filling a hydrophobic binding pocket (pocket D) with nonencoded aromatic amino acids. Three peptides with altered side chains (alpha-naphthylalanine, betanaphthylalanine and homophenylalanine) in position 3 were synthesised. The thermal denaturation profiles of the HLA protein in complex with the modified peptides, monitored by circular dichroism spectroscopy, showed a significant shift towards higher melting temperatures with respect to the parent T cell epitope. The proposed binding mode of the nonnatural peptides was checked by site-directed mutagenesis of the pocket D, hypothesised to accommodate the large hydrophobic side chains. Reducing the size and depth of the pocket by mutating Leu 156 into Trp only affects the binding of the non-natural ligands, thus providing experimental evidence that the nonnatural peptide amino acids bind as predicted to the host MHC protein.
AuthorsS Krebs, G Folkers, D Rognan
JournalJournal of peptide science : an official publication of the European Peptide Society (J Pept Sci) Vol. 4 Issue 6 Pg. 378-88 (Sep 1998) ISSN: 1075-2617 [Print] England
PMID9796857 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • HLA-B27 Antigen
  • Peptides
  • Recombinant Proteins
Topics
  • Amino Acid Sequence
  • Base Sequence
  • Chromatography, Gel
  • Circular Dichroism
  • DNA Primers
  • HLA-B27 Antigen (genetics, metabolism)
  • Humans
  • Models, Molecular
  • Mutagenesis, Site-Directed
  • Peptides (chemical synthesis, metabolism)
  • Protein Binding
  • Recombinant Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: